Effects of a single dose of methylprednisolone versus three doses of rosiglitazone on nerve growth factor levels after spinal cord injury

Journal of International Medical Research

Volumn 39, Issue 3, 2011, Pages 805-814

  Meng, B ^a   Zhang, Q ^b   Huang, C ^a   Zhang, H T ^a   Tang, T ^a   Yang, H I ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b Yuncheng County People's Hospital   (China)

Author keywords

Brain derived neurotrophic factor; Functional recovery; Methylprednisolone; Nerve growth factor; Peroxisome proliferator activated receptor Agonists; Rosiglitazone; Spinal cord injury

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; METHYLPREDNISOLONE SODIUM SUCCINATE; NERVE GROWTH FACTOR; NEUROTROPHIN; ROSIGLITAZONE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONTUSION; CONVALESCENCE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; GENE; LAMINECTOMY; MOTOR PERFORMANCE; NERVE GROWTH; NERVE REGENERATION; NEUROTROPHIN GENE; NONHUMAN; POSTOPERATIVE CARE; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; SPINAL CORD INJURY; TISSUE LEVEL;

EID: 80052245872     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900313     Document Type: Article

References (43)

1. McTigue DM: Potential therapeutic targets for PPARγ after spinal cord injury. PPAR Res 2008; 2008: article ID 517162.
2. Kwon BK, Tetzlaff W, Grauer JN, et al: Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 2004; 4: 451-464.
3. Frigon A, Rossignol S: Functional plasticity following spinal cord lesions. Prog Brain Res 2006; 157: 231-260.
4. Jones TB, McDaniel EE, Popovich PG: Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 2005; 11: 1223-1236.
5. Lehrke M, Lazar MA: The many faces of PPARγ. Cell 2005; 123: 993-999.
6. Tolman KG, Chandramouli J: Hepatotoxicity of the thiazolidinediones. Clin Liver Dis 2003; 7: 369-379.
7. Kiaei M, Kipiani K, Chen J, et al: Peroxisome proliferator-activated receptor-γ agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol 2005; 191: 331-336.
8. Dehmer T, Heneka MT, Sastre M, et al: Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation. J Neurochem 2004; 88: 494-501.
9. Victor NA, Wanderi EW, Gamboa J, et al: Altered PPARγ expression and activation after transient focal ischemia in rats. Eur J Neurosci 2006; 24: 1653-1663.
10. Yi JH, Park SW, Brooks N, et al: PPARγ agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and antioxidative mechanisms. Brain Res 2008; 1244: 164-172.
11. McTigue DM, Tripathi R, Wei P, et al: The PPARγ agonist pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury. Exp Neurol 2007; 205: 396-406.
12. Park SW, Yi JH, Miranpuri G, et al: Thiazolidinedione class of peroxisome proliferator-activated receptor γ agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J Pharmacol Exp Ther 2007; 320: 1002-1012.
13. Liu N, Han S, Lu PH, et al: Upregulation of annexins I, II, and V after traumatic spinal cord injury in adult rats. J Neurosci Res 2004; 77: 391-401.
14. Basso DM, Beattie MS, Bresnahan JC: Graded histological and locomotor outcomes after spinal cord contusion using the NYU weightdrop device versus transection. Exp Neurol 1996; 139: 244-256.
15. Tureyen K, Brooks N, Bowen K, et al: Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia. J Neurochem 2008; 105: 1313-1324.
16. Levi-Montalcini R, Hamburger V: Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool 1951; 116: 321-361.
17. Widenfalk J, Lundströmer K, Jubran M, et al: Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid. J Neurosci 2001; 21: 3457-3475.
18. Qin DX, Zou XL, Luo W, et al: Expression of some neurotrophins in the spinal motoneurons after cord hemisection in adult rats. Neurosci Lett 2006; 410: 222-227.
19. Rocamora N, Pascual M, Acsàdy L, et al: Expression of NGF and NT3 mRNAs in hippocampal interneurons innervated by the GABAergic septohippocampal pathway. J Neurosci 1996; 16: 3991-4004.
20. Deller T, Haas CA, Freiman TM, et al: Lesioninduced axonal sprouting in the central nervous system. Adv Exp Med Biol 2006; 557: 101-121.
21. Bakhit C, Armanini M, Wong WLT, et al: Increase in nerve growth factor-like immunoreactivity and decrease in choline acetyltransferase following contusive spinal cord injury. Brain Res 1991; 554: 264-271.
22. Bennett AD, Taglialatela G, Perez-Polo R, et al: NGF levels decrease in the spinal cord and dorsal root ganglia after spinal hemisection. Neuroreport 1999; 10: 889-893.
23. Oudega M, Hagg T: Nerve growth factor promotes regeneration of sensory axons into adult rat spinal cord. Exp Neurol 1996; 140: 218-229.
24. Murakami Y, Furukawa S, Nitta A, et al: Accumulation of NGF protein at both rostral and caudal stumps in the transected rat spinal cord. J Neurol Sci 2002; 198: 63-69.
25. Beattie MS, Harrington AW, Lee R, et al: ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 2002; 36: 375-386.
26. Brown A, Ricci MJ, Weaver LC: NGF mRNA is expressed in the dorsal root ganglia after spinal cord injury in the rat. Exp Neurol 205: 283-286.
27. Li XL, Zhang W, Zhou X, et al: Temporal changes in the expression of some neurotrophins in spinal cord transected adult rats. Neuropeptides 2007; 41: 135-143.
28. Marsh DR, Wong ST, Meakin SO, et al: Neutralizing intraspinal nerve growth factor with a trkA-IgG fusion protein blocks the development of autonomic dysreflexia in a clip-compression model of spinal cord injury. J Neurotrauma 2002; 19: 1531-1541.
29. la Sala A, Corinti S, Federici M, et al: Ligand activation of NGF receptor TrkA protects monocytes from apoptosis. J Leukoc Biol 2000; 68: 104-110.
30. Popovich PG, van Rooijen N, Hickey WF, et al: Hematogenous macrophages express CD8 and distribute to regions of lesion cavitation after spinal cord injury. Exp Neurol 2003; 182: 275-287.
31. Levi-Montalcini R, Skaper SD, Dal Toso R, et al: Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 1996; 19: 514-520.
32. Torcia M, Bracci-Laudiero L, Lucibello M, et al: Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996; 85: 345-356.
33. Blanquart C, Barbier O, Fruchart JC, et al: Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol 2003; 85: 267-273.
34. Escher P, Wahli W: Peroxisome proliferatoractivated receptors: insight into multiple cellular functions. Mutat Res 2000; 448: 121-138.
35. Fuenzalida KM, Aguilera MC, Piderit DG, et al: Peroxisome proliferator-activated receptor γ is a novel target of the NGF signaling pathway in PC12 cells. J Biol Chem 2005; 280: 9604-9609.
36. Leypold BG, Flanders AE, Schwartz ED, et al: The impact of methylprednisolone on lesion severity following spinal cord injury. Spine (Phila Pa 1976) 2007; 32: 373-378.
37. Pereira JE, Costa LM, Cabrita AM, et al: Methylprednisolone fails to improve functional and histological outcome following spinal cord injury in rats. Exp Neurol 2009; 220: 71-81.
38. Jiang S, Khan MI, Middlemiss PJ, et al: AIT-082 and methylprednisolone singly, but not in combination, enhance functional and histological improvement after acute spinal cord injury in rats. Int J Immunopathol Pharmacol 2004; 17: 353-366.
39. Saville LR, Pospisil CH, Mawhinney LA, et al: A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment. J Neuroimmunol 2004; 156: 42-57.
40. Chvatal SA, Kim YT, Bratt-Leal AM, et al: Spatial distribution and acute anti-inflammatory effects of methylprednisolone after sustained local delivery to the contused spinal cord. Biomaterials 2008; 29: 1967-1975.
41. Hayashi M, Ueyama T, Tamaki T, et al: Expression of neurotrophin and IL-1 beta mRNAs following spinal cord injury and the effects of methylprednisolone treatment. Kaibogaku Zasshi 1997; 72: 209-213 [in Japanese, English abstract].
42. Tsai MC, Wei CP, Lee DY, et al: Inflammatory mediators of cerebrospinal fluid from patients with spinal cord injury. Surg Neurol 2008; 70(suppl 1): 19-24.
43. Chang CN, Yang JT, Lee TH, et al: Dexamethasone enhances upregulation of nerve growth factor mRNA expression in ischemic rat brain. J Clin Neurosci 2005; 12: 680-684.